The Artificial Retina Market segments across device design, implantation site, power and processing architecture, clinical indication, and care setting. By device design, epiretinal systems place electrode arrays on the inner retinal surface and rely on external cameras and processors to translate scenes into stimulation patterns. Subretinal systems position miniature photovoltaic or microelectrode arrays behind the retina to leverage ambient light and intrinsic retinal circuitry, often yielding more naturalistic perception. Suprachoroidal approaches emphasize surgical simplicity and future expandability, while research continues into cortical visual prostheses for late-stage degeneration where the optic pathway remains viable. Indication-wise, retinitis pigmentosa and advanced macular degeneration dominate demand, with exploratory work for other inherited dystrophies. End users include tertiary ophthalmology centers, academic hospitals, and specialized private clinics with imaging, electrophysiology, and rehabilitation capabilities. Segmentation by power and processing distinguishes tethered camera systems from emerging wirelessly powered, on-chip processing designs that shrink wearables and simplify daily use. Geography further segments adoption, with established reimbursement guiding mature markets and philanthropic or public programs supporting access in developing regions. This layered segmentation highlights how clinical needs, surgical preferences, and health-system economics jointly shape product-market fit.